Leerink Partners Maintains Outperform on BrightSpring Health, Raises Price Target to $92

Benzinga · 4d ago
Leerink Partners analyst Whit Mayo maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $72 to $92.